Tuesday, February 28, 2017

BRIEF-Amgen announces positive results from planned overall survival analysis of phase 3 head-to-head ENDEAVOR trial

* Announces positive results from planned overall survival

analysis of phase 3 head-to-head ENDEAVOR trial

Read more

No comments:

Post a Comment